Latest News for: MDS

Edit

Gujarat govt transfers 26 IAS officers including MDs of GNFC & GSPC

Business Line 23 Dec 2025
Avantika Singh Aulakh, ...
Edit

White coat ceremony for new BDS & MDS students at PU dental institute

The Times of India 11 Dec 2025
+Text SizeSmallMediumLarge. .
Edit

Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition (Form 8-K) (Rigel Pharmaceuticals Inc)

Public Technologies 10 Dec 2025
"New therapies are needed for patients with transfusion dependent lower-risk MDS ... R289 was generally well tolerated across all dose groups in this heavily pre-treated lower-risk MDS patient population, the majority of whom were HTB at baseline.
Edit

Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025

Missoulian 09 Dec 2025
– New findings demonstrate a 72% HI-E response rate at Week 16 with meaningful hemoglobin improvement – ... .
Edit

Celebrating a Milestone: The 10th Annual MDS-PAS Movement Disorders School (The Michael J Fox Foundation for Parkinson's Research)

Public Technologies 09 Dec 2025
Safra Foundation sponsored the International Parkinson and Movement Disorder Society Pan American Section (MDS-PAS) 10th annual Movement Disorders School for Neurology Residents, held in Denver this September ... Disclaimer.
Edit

Correlation between Treatment-Emergent Cytopenias and Clinical Response with Imetelstat (IME) in Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (LR-MDS): Analysis from the IMerge Trial (Geron Corporation)

Public Technologies 08 Dec 2025
ANC, absolute neutrophil count; LR, lower risk; MDS, myelodysplastic syndromes; RBC, red blood cell; TEAE, treatment-emergent adverse event; TI, transfusion independence ... IPSS low- or INT-1-risk MDS ... IPSS low- or INT-1-risk MDS.
Edit

Faron Presents Updated BEXMAB Data at ASH 2025: Deep and Durable Responses in HR-MDS with Favorable Safety Profile

Pharmiweb 08 Dec 2025
TURKU, FI / ACCESS Newswire / December 8, 2025 / Faron Pharmaceuticals (HEL.FARON)(LSE.FARN) - Significant efficacy observed in TP53-mutated patients with a 70% complete remission rate in the frontline HR MDS.
Edit

Long-Term Outcomes from Randomized, Double-Blind, Placebo-Controlled, Phase 3 IMerge Trial of Imetelstat for Lower-Risk Myelodysplastic Syndromes (LR-MDS) (Geron Corporation)

Public Technologies 08 Dec 2025
Imetelstat, a first-in-class telomerase inhibitor, was approved in the United States (US) and Europe for the treatment of adult patients with LR-MDS and RBC-TD anemia (defined in the US label as requiring ... IPSS low-risk or intermediate-1-risk MDS.
Edit

Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition (Rigel Pharmaceuticals Inc)

Public Technologies 07 Dec 2025
... R289 as a therapeutic for MDS and lower-risk MDS, the existence of patients with an unmet medical need for such therapy, and Rigel's ability to further develop its clinical stage product candidates.
Edit

Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition

PR Newswire 07 Dec 2025
... R289 as a therapeutic for MDS and lower-risk MDS, the existence of patients with an unmet medical need for such therapy, and Rigel's ability to further develop its clinical stage product candidates.
Edit

Aggiornamento PT web based REBLOZYL MDS (Italian Medicines Agency)

Public Technologies 24 Nov 2025
) Si informano gli utenti dei Registri Farmaci sottoposti a Monitoraggio che, a seguito dell'entrata in vigore della Determina AIFA n ... n ... Attachments Original document Permalink. Disclaimer ... (noodl.
Edit

SPECIAL REPORT: Alleged $1bn NestOil Debt: First Bank, Access Bank, Zenith Bank MDs Risk Imprisonment Over Disobedience to Court Order

This Day 24 Nov 2025
Nigeria . 49 seconds ago. Wale Igbintade ... The warnings were contained in a series of Form 48 Notices of Consequences of Disobedience to Court Order, issued in relation to an interim directive made on November 6, 2025, in Suit No. FHC/ABJ/CS/2369/2025 ... .
Edit

Your Words: Thanks for supporting the work of MDS at annual road race event

The Keene Sentinel 20 Nov 2025
This year’s Run~Walk~Smile 5k/10K/1-mile road races ...
Edit

Young Wall Street, pay attention: 5 new Goldman MDs share their best tips for getting ...

Business Insider 13 Nov 2025
These MDs sit across the global bank, from asset and wealth management to global investment research to mergers and acquisitions and private wealth.
Edit

49 India employees among the Goldman Sachs’ 2025 managing directors, largest-ever class of MDs in India

The Times of India 07 Nov 2025
.

Article Search

tools
×
×
×
×